Bismuth/ofloxacin combination for duodenal ulcer.
D000890:Anti-Infective Agents / Q000008:administration & dosage*; D001729:Bismuth; D002169:Campylobacter Infections / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy*; D006801:Humans; D015242:Ofloxacin; D009942:Organometallic Compounds / Q000008:administration & dosage*; D010078:Oxazines / Q000008:administration & dosage*; D011897:Random Allocation; D012459:Salicylates / Q000008:administration & dosage*
D000890:Anti-Infective Agents; D009942:Organometallic Compounds; D010078:Oxazines; D012459:Salicylates; C015715:bismuth subsalicylate; D015242:Ofloxacin; D001729:Bismuth